苑东生物: 苑东生物：关于参加2025年半年度科创板创新药行业集体业绩说明会的公告

Core Viewpoint - Chengdu Easton Biopharmaceutical Co., Ltd. will participate in the 2025 semi-annual performance briefing for the innovative drug industry on September 16, 2025, to enhance communication with investors regarding its operational results and financial indicators for the first half of 2025 [1][2]. Group 1: Meeting Details - The meeting is scheduled for September 16, 2025, from 15:00 to 17:00 [2]. - The location of the meeting is the Shanghai Stock Exchange Roadshow Center, accessible via the website: https://roadshow.sseinfo.com/ [2][4]. - The format of the meeting will be an online interactive session [2][4]. Group 2: Participants and Interaction - Key participants include General Manager Yuan Mingxu, Board Secretary Li Shuyun, and Chief Financial Officer Bo Xiaoqin [2]. - Investors can participate online during the meeting and submit questions in advance from September 8 to September 15, 2025, by visiting the Roadshow Center or emailing the company [2][4]. Group 3: Contact Information - For inquiries, investors can contact the Securities Department at 028-86106668 or via email at ydsw@eastonpharma.cn [3].